Primitive Neuroectodermal Tumor — Trials

Primitive Neuroectodermal Tumor — Trials · CancerIndex

Clinical trials

Registered studies

673 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 146
Recruiting: 80
Ph III recruiting: 8
Growth YoY: −33.3%
Industry share: 9%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (86)

clinicaltrialsPublishedShowing 51–69 of 69 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07399821	An Imaging Study of Anti-GD2-800CW in Patients With Neuroblastoma(GLOW-FISH)	recruiting	Phase 1 / Phase 2	22	Princess Maxima Center for Pediatric OncologyOTHER	1	Feb 10, 2026	clinicaltrials
NCT07334301	A Multi-Arm, Platform Trial For Relapsed Neuroblastoma(BEACON2)	recruiting	Phase 1 / Phase 2	160	University of BirminghamOTHER	5	Jan 12, 2026